It was also found that interruption of the IL-23/IL-17 cascade could decrease infarct size and improve neurological outcome after ischemic stroke (Arunachalam et al., 2017; Gelderblom et al., 2018). The gene discussed is IL17A; the disease is ischemic stroke.